[Hypercalcemic crisis].
Tahara
Hideki
H
Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine.
D002116:Calcitonin / Q000008:administration & dosage; D016638:Critical Illness; D003937:Diagnosis, Differential; D003956:Dialysis; D004164:Diphosphonates / Q000008:administration & dosage; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006934:Hypercalcemia / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D049950:Hyperparathyroidism, Primary / Q000150:complications; D009369:Neoplasms / Q000150:complications; D011379:Prognosis; D012965:Sodium Chloride / Q000008:administration & dosage; D049994:Sodium Potassium Chloride Symporter Inhibitors / Q000008:administration & dosage; D014807:Vitamin D / Q000506:poisoning
D004164:Diphosphonates; D005938:Glucocorticoids; D049994:Sodium Potassium Chloride Symporter Inhibitors; D014807:Vitamin D; D012965:Sodium Chloride; D002116:Calcitonin